×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VERV – verve therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VERV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
10:00 am
verv
Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation
12/17
05:42 am
verv
Verve Therapeutics Slides As Insider Purchases Lose Another US$65k [Yahoo! Finance]
Low
Report
Verve Therapeutics Slides As Insider Purchases Lose Another US$65k [Yahoo! Finance]
12/15
10:00 am
verv
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out
12/13
10:15 am
verv
VERV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Verve Therapeutics, Inc. and Encourages Investors to Contact the Firm
Medium
Report
VERV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Verve Therapeutics, Inc. and Encourages Investors to Contact the Firm
11/29
04:05 pm
verv
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
High
Report
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/6
01:10 pm
verv
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $32.00. They now have a "buy" rating on the stock.
11/6
12:23 pm
verv
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target lowered by analysts at Royal Bank of Canada from $20.00 to $17.00. They now have an "outperform" rating on the stock.
Low
Report
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target lowered by analysts at Royal Bank of Canada from $20.00 to $17.00. They now have an "outperform" rating on the stock.
11/6
09:30 am
verv
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target lowered by analysts at HC Wainwright from $15.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
Verve Therapeutics, Inc. (NASDAQ: VERV) had its price target lowered by analysts at HC Wainwright from $15.00 to $14.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Headline
Impact
12/4
04:30 pm
verv
Form 4 Verve Therapeutics, Inc. For: Dec 04 Filed by: Kathiresan Sekar
Medium
Report
Form 4 Verve Therapeutics, Inc. For: Dec 04 Filed by: Kathiresan Sekar
12/3
04:30 pm
verv
Form 4 Verve Therapeutics, Inc. For: Nov 29 Filed by: Dorval Allison
Medium
Report
Form 4 Verve Therapeutics, Inc. For: Nov 29 Filed by: Dorval Allison
11/18
05:24 pm
verv
Form SC 13G Verve Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G Verve Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
11/12
05:53 pm
verv
Form SC 13G/A Verve Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SC 13G/A Verve Therapeutics, Inc. Filed by: VANGUARD GROUP INC
11/8
02:21 pm
verv
Form SC 13G/A Verve Therapeutics, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A Verve Therapeutics, Inc. Filed by: BlackRock, Inc.
11/5
07:31 am
verv
Form 10-Q Verve Therapeutics, Inc. For: Sep 30
Low
Report
Form 10-Q Verve Therapeutics, Inc. For: Sep 30
11/5
07:15 am
verv
Form 8-K Verve Therapeutics, Inc. For: Nov 05
Medium
Report
Form 8-K Verve Therapeutics, Inc. For: Nov 05
11/4
01:53 pm
verv
Form SC 13G/A Verve Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Verve Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: